Self-complementary AAV-mediated gene therapy restores cone function and prevents cone degeneration in two models of Rpe65 deficiency

March 19, 2010 — admin |

Authors: J Pang, S E Boye, B Lei, S L Boye, D Everhart, R Ryals, Y Umino, B Rohrer, J Alexander, J Li, X Dai, Q Li, B Chang, R Barlow
& W W Hauswirth (Source: Gene Therapy)

Posted in Longevity Medicine. RSS. Trackback.

Comments are closed.

« FDA panel recommends Boston Scientific’s electronic heart device for less-severe heart disease
Conquering TB: How Genomic Information And Tools Can Lead To New Tuberculosis Therapies That Combat Drug Resistance »